background serotonin transporter involved pulmonary artery smooth muscle hyperplasia leads pulmonary hypertension ph hypoxia gene polymorphism control expression examined gene polymorphism ph hypoxemic patients advanced chronic obstructive pulmonary disease copd methods results NUMBER patients copd recruited france n67 uk n36 determined gene polymorphism pulmonary artery pressure pap measured right heart catheterization france doppler echocardiography uk subjects NUMBER countries served control subjects distribution gene polymorphism did differ patients control subjects patients carrying ll genotype associated higher levels expression pulmonary artery smooth muscle cells ls ss genotypes ph severe ls ss patients mean pap values patients france ll ls ss genotypes mm hg respectively p001 corresponding systolic pap values uk mm hg respectively p001 compared control subjects platelet protein increased copd patients proportion hypoxemia level strong immunostaining observed remodeled pulmonary arteries copd patients conclusions gene polymorphism appears determine severity ph hypoxemic patients copd ph important prognostic factor disease recognition patients risk ph helpful managing copd NUMBER htt NUMBER htt NUMBER htt NUMBER htt NUMBER htt ninety NUMBER htt NUMBER htt NUMBER NUMBER sem NUMBER NUMBER NUMBER htt NUMBER htt NUMBER htt NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER mean NUMBER NUMBER